RA

Reena Arya

Active Director Director DIN 08758953
DIN 08758953 First appointment Jun 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2020
Shareholding value •••• Premium profile

About Reena Arya

Data last updated:

Reena Arya is a Director at Sunovion Pharmaceuticals (India) Private Limited (since 2020). The company operates in Trading. Sunovion Pharmaceuticals (India) Private Limited reported revenue of ₹73.7 Lakh (FY 2025).

DIN 08758953
Primary Designation Director
Industry Trading
First Appointment 10 Jun 2020
Oldest Company Age 6 yrs
Largest company Sunovion Pharmaceuticals (India) Private Limited · ₹73.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Jun 20202020₹73.7 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Sunovion Pharmaceuticals (India) Private Limited
Premium access

Shareholding and investment profile for Reena Arya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Arya

Reena Arya currently holds 1 directorship: Sunovion Pharmaceuticals (India) Private Limited (Director, since 10 Jun 2020, revenue ₹73.7 Lakh (FY 2025)).

Reena Arya was first appointed on 10 Jun 2020 as Director at Sunovion Pharmaceuticals (India) Private Limited.

The current boards of Reena Arya's companies include Aashirwaad Chaurasia (Sunovion Pharmaceuticals (India) Private Limited), Abhay Pratap Singh (Sunovion Pharmaceuticals (India) Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available